{"pmid":32389848,"title":"Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year, Southeastern France.","text":["Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year, Southeastern France.","Respiratory viruses are a major global cause of mortality worldwide and in France where they cause several thousands of deaths yearly. University Hospital Institute-Mediterranee Infection performs real-time surveillance of all diagnoses of infections and associated deaths in public hospitals of Marseille, Southeastern France. Here, mortality associated with diagnoses of respiratory viruses was compared during colder months of 2018-2019 and 2019-2020 (week 47-week 14). In 2018-2019, 73 patients (0.17% of 42,851 hospitalized patients) died after being diagnosed with a respiratory virus; 40 and 13 deaths occurred in patients diagnosed with influenza A virus and respiratory syncytial virus (RSV), respectively. In 2019-2020, 50 patients (0.10% of 49,043 patients hospitalized) died after being diagnosed with a common respiratory virus; 7 and 7 deaths occurred in patients diagnosed with influenza A virus and RSV, respectively. Additionally, 55 patients died after being diagnosed with SARS-CoV-2. The proportion of respiratory virus-associated deaths among hospitalized patients was thus significantly lower for common respiratory viruses in 2019-2020 than in 2018-2019 (102 versus 170 per 100,000 hospitalized patients; p=0.003), majoritarily as a consequence of a decrease in influenza A virus (-83%) and RSV (-46%)-associated deaths. Overall, the proportion of respiratory virus-associated deaths among hospitalized patients was higher but not significantly in 2019-2020 than in 2018-2019 (214 versus 170 per 100,000 hospitalized patients; p=0.08, Yates-corrected chi-square test). These findings allow putting into perspective the death burden of SARS-CoV-2 infections in our geographical area.","Int J Infect Dis","Giraud-Gatineau, Audrey","Colson, Philippe","Jimeno, Marie-Therese","Zandotti, Christine","Ninove, Laetitia","Boschi, Celine","Lagier, Jean-Christophe","Scola, Bernard LA","Chaudet, Herve","Raoult, Didier","32389848"],"abstract":["Respiratory viruses are a major global cause of mortality worldwide and in France where they cause several thousands of deaths yearly. University Hospital Institute-Mediterranee Infection performs real-time surveillance of all diagnoses of infections and associated deaths in public hospitals of Marseille, Southeastern France. Here, mortality associated with diagnoses of respiratory viruses was compared during colder months of 2018-2019 and 2019-2020 (week 47-week 14). In 2018-2019, 73 patients (0.17% of 42,851 hospitalized patients) died after being diagnosed with a respiratory virus; 40 and 13 deaths occurred in patients diagnosed with influenza A virus and respiratory syncytial virus (RSV), respectively. In 2019-2020, 50 patients (0.10% of 49,043 patients hospitalized) died after being diagnosed with a common respiratory virus; 7 and 7 deaths occurred in patients diagnosed with influenza A virus and RSV, respectively. Additionally, 55 patients died after being diagnosed with SARS-CoV-2. The proportion of respiratory virus-associated deaths among hospitalized patients was thus significantly lower for common respiratory viruses in 2019-2020 than in 2018-2019 (102 versus 170 per 100,000 hospitalized patients; p=0.003), majoritarily as a consequence of a decrease in influenza A virus (-83%) and RSV (-46%)-associated deaths. Overall, the proportion of respiratory virus-associated deaths among hospitalized patients was higher but not significantly in 2019-2020 than in 2018-2019 (214 versus 170 per 100,000 hospitalized patients; p=0.08, Yates-corrected chi-square test). These findings allow putting into perspective the death burden of SARS-CoV-2 infections in our geographical area."],"journal":"Int J Infect Dis","authors":["Giraud-Gatineau, Audrey","Colson, Philippe","Jimeno, Marie-Therese","Zandotti, Christine","Ninove, Laetitia","Boschi, Celine","Lagier, Jean-Christophe","Scola, Bernard LA","Chaudet, Herve","Raoult, Didier"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389848","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijid.2020.05.001","keywords":["france","respiratory viruses","sars-cov-2","influenza virus","mortality"],"locations":["France","Marseille","France"],"countries":["France"],"countries_codes":["FRA|France"],"weight":0,"_version_":1666528580223369217,"score":9.490897,"similar":[{"pmid":32389850,"title":"Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing.","text":["Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing.","BACKGROUND: Coronavirus disease 2019 (COVID-19) is spreading. Here, we summarized the composition of pathogens in fever clinic patients and analyzed characteristics of different respiratory virus infection. METHODS: Retrospectively collected patients with definite etiological results using nasal and pharyngeal swabs in fever clinic. RESULTS: Totally, 1860 patients were screened and 136 patients were enrolled. 72 (52.94%) of them were diagnosed as influenza (Flu) A virus infection. 32 (23.53%) of them were diagnosed as Flu B virus infection. 18 (13.24%) and 14 (10.29%) of them were diagnosed as COVID-19 and respiratory syncytial virus (RSV) infection respectively. COVID-19 group had a higher rate of contact with epidemic area within 14 days and clustering onset than other groups. Fever was the most common symptom in these patients. The ratio of fever and the highest temperature were higher in Flu A virus infection patients than in COVID-19 patients. COVID-19 patients had lower white blood cell count and neutrophil count than Flu A virus and RSV infection group, but higher lymphocyte count than Flu A and B virus infection groups. COVID-19 group (83.33%) had higher rate of pneumonia in chest CT scan than Flu A and B virus infection groups. CONCLUSIONS: Influenza viruses accounted for a large proportion of respiratory virus infection even during the epidemic of COVID-19 in Beijing. No single symptom or laboratory finding was suggestive of specific respiratory virus, however, epidemic history was important for screening of COVID-19.","Int J Infect Dis","Li, Yan","Wang, Jiangshan","Wang, Chunting","Yang, Qiwen","Xu, Yingchun","Xu, Jun","Li, Yi","Yu, Xuezhong","Zhu, Huadong","Liu, Jihai","32389850"],"abstract":["BACKGROUND: Coronavirus disease 2019 (COVID-19) is spreading. Here, we summarized the composition of pathogens in fever clinic patients and analyzed characteristics of different respiratory virus infection. METHODS: Retrospectively collected patients with definite etiological results using nasal and pharyngeal swabs in fever clinic. RESULTS: Totally, 1860 patients were screened and 136 patients were enrolled. 72 (52.94%) of them were diagnosed as influenza (Flu) A virus infection. 32 (23.53%) of them were diagnosed as Flu B virus infection. 18 (13.24%) and 14 (10.29%) of them were diagnosed as COVID-19 and respiratory syncytial virus (RSV) infection respectively. COVID-19 group had a higher rate of contact with epidemic area within 14 days and clustering onset than other groups. Fever was the most common symptom in these patients. The ratio of fever and the highest temperature were higher in Flu A virus infection patients than in COVID-19 patients. COVID-19 patients had lower white blood cell count and neutrophil count than Flu A virus and RSV infection group, but higher lymphocyte count than Flu A and B virus infection groups. COVID-19 group (83.33%) had higher rate of pneumonia in chest CT scan than Flu A and B virus infection groups. CONCLUSIONS: Influenza viruses accounted for a large proportion of respiratory virus infection even during the epidemic of COVID-19 in Beijing. No single symptom or laboratory finding was suggestive of specific respiratory virus, however, epidemic history was important for screening of COVID-19."],"journal":"Int J Infect Dis","authors":["Li, Yan","Wang, Jiangshan","Wang, Chunting","Yang, Qiwen","Xu, Yingchun","Xu, Jun","Li, Yi","Yu, Xuezhong","Zhu, Huadong","Liu, Jihai"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389850","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijid.2020.05.008","keywords":["2019 novel coronavirus","covid-19","infection","influenza","virus"],"locations":["neutrophil","Beijing","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666528579975905280,"score":203.3495},{"pmid":32453196,"title":"A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses.","text":["A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses.","BACKGROUND: Human coronaviruses (HCoVs) have been recognized as causative agents of respiratory tract infections.Our aim was to describe HCoV infections in hospitalized children in a prospective surveillance study for 14 years and compare them with other respiratory viruses. METHODS: As a part of an ongoing prospective study to identify the etiology of viral respiratory infections in Spain, we performed the analysis of HCoV infections in children hospitalized in a secondary hospital in Madrid, between October 2005 and June 2018. Clinical data of HCoV patients were compared with those infected by rhinovirus, respiratory syncytial virus and influenza. RESULTS: The study population consisted of 5131 hospitalizations for respiratory causes in children. A total of 3901 cases (75.9%) had a positive viral identification and 205 cases (4.1%) were positive for HCoV. Only 41 cases (20%) of HCoV infection were detected as single infections. Episodes of recurrent wheezing were the most common diagnosis, and 112 children (54%) had hypoxia. Clinical data in HCoV cases were similar to those associated with rhinovirus; however, patients with HCoV were younger. Other viruses were associated with hypoxia more frequently than cases with HCoV; high fever was more common in influenza infections and bronchiolitis in respiratory syncytial virus group. Although a slight peak of circulation appears mostly in winter, HCoV has been detected throughout the year as well. CONCLUSIONS: HCoV infections represent a small fraction of respiratory infections that require hospitalization in children and their characteristics do not differ greatly from other respiratory viral infections.","Pediatr Infect Dis J","Calvo, Cristina","Alcolea, Sonia","Casas, Inmaculada","Pozo, Francisco","Iglesias, Maria","Gonzalez-Esguevillas, Monica","Luz Garcia-Garcia, Maria","32453196"],"abstract":["BACKGROUND: Human coronaviruses (HCoVs) have been recognized as causative agents of respiratory tract infections.Our aim was to describe HCoV infections in hospitalized children in a prospective surveillance study for 14 years and compare them with other respiratory viruses. METHODS: As a part of an ongoing prospective study to identify the etiology of viral respiratory infections in Spain, we performed the analysis of HCoV infections in children hospitalized in a secondary hospital in Madrid, between October 2005 and June 2018. Clinical data of HCoV patients were compared with those infected by rhinovirus, respiratory syncytial virus and influenza. RESULTS: The study population consisted of 5131 hospitalizations for respiratory causes in children. A total of 3901 cases (75.9%) had a positive viral identification and 205 cases (4.1%) were positive for HCoV. Only 41 cases (20%) of HCoV infection were detected as single infections. Episodes of recurrent wheezing were the most common diagnosis, and 112 children (54%) had hypoxia. Clinical data in HCoV cases were similar to those associated with rhinovirus; however, patients with HCoV were younger. Other viruses were associated with hypoxia more frequently than cases with HCoV; high fever was more common in influenza infections and bronchiolitis in respiratory syncytial virus group. Although a slight peak of circulation appears mostly in winter, HCoV has been detected throughout the year as well. CONCLUSIONS: HCoV infections represent a small fraction of respiratory infections that require hospitalization in children and their characteristics do not differ greatly from other respiratory viral infections."],"journal":"Pediatr Infect Dis J","authors":["Calvo, Cristina","Alcolea, Sonia","Casas, Inmaculada","Pozo, Francisco","Iglesias, Maria","Gonzalez-Esguevillas, Monica","Luz Garcia-Garcia, Maria"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453196","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/INF.0000000000002760","locations":["Spain","Madrid","hypoxia"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Diagnosis"],"weight":1,"_version_":1667881798573490176,"score":191.29745},{"pmid":32205269,"pmcid":"PMC7102626","title":"Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot.","text":["Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot.","BACKGROUND: Rapid virological diagnosis is needed to limit the length of isolation for suspected COVID-19 cases. METHOD: We managed the first 280 patients suspected to have COVID-19 through a rapid care circuit and virological diagnosis in our infectious disease reference hospital in Marseille, France. Rapid viral detection was performed on sputum and nasopharyngeal samples. RESULTS: Over our study period, no SARS-CoV-2 was detected. Results were obtained within approximately 3 h of the arrival of patient samples at the laboratory. Other viral infections were identified in 49% of the patients, with most common pathogens being influenza A and B viruses, rhinovirus, metapneumovirus and common coronaviruses, notably HKU1 and NL63. CONCLUSION: Early recognition of COVID-19 is critical to isolate confirmed cases and prevent further transmission. Early rule-out of COVID-19 allows public health containment measures to be adjusted by reducing the time spent in isolation.","Travel Med Infect Dis","Amrane, Sophie","Tissot-Dupont, Herve","Doudier, Barbara","Eldin, Carole","Hocquart, Marie","Mailhe, Morgane","Dudouet, Pierre","Ormieres, Etienne","Ailhaud, Lucie","Parola, Philippe","Lagier, Jean-Christophe","Brouqui, Philippe","Zandotti, Christine","Ninove, Laetitia","Luciani, Lea","Boschi, Celine","La Scola, Bernard","Raoult, Didier","Million, Matthieu","Colson, Philippe","Gautret, Philippe","32205269"],"abstract":["BACKGROUND: Rapid virological diagnosis is needed to limit the length of isolation for suspected COVID-19 cases. METHOD: We managed the first 280 patients suspected to have COVID-19 through a rapid care circuit and virological diagnosis in our infectious disease reference hospital in Marseille, France. Rapid viral detection was performed on sputum and nasopharyngeal samples. RESULTS: Over our study period, no SARS-CoV-2 was detected. Results were obtained within approximately 3 h of the arrival of patient samples at the laboratory. Other viral infections were identified in 49% of the patients, with most common pathogens being influenza A and B viruses, rhinovirus, metapneumovirus and common coronaviruses, notably HKU1 and NL63. CONCLUSION: Early recognition of COVID-19 is critical to isolate confirmed cases and prevent further transmission. Early rule-out of COVID-19 allows public health containment measures to be adjusted by reducing the time spent in isolation."],"journal":"Travel Med Infect Dis","authors":["Amrane, Sophie","Tissot-Dupont, Herve","Doudier, Barbara","Eldin, Carole","Hocquart, Marie","Mailhe, Morgane","Dudouet, Pierre","Ormieres, Etienne","Ailhaud, Lucie","Parola, Philippe","Lagier, Jean-Christophe","Brouqui, Philippe","Zandotti, Christine","Ninove, Laetitia","Luciani, Lea","Boschi, Celine","La Scola, Bernard","Raoult, Didier","Million, Matthieu","Colson, Philippe","Gautret, Philippe"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32205269","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.tmaid.2020.101632","keywords":["covid-19","coronaviruses","epidemic","influenza","sars-cov-2","travel"],"locations":["Marseille","France","rhinovirus","Marseille","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis"],"weight":1,"_version_":1666138490157400066,"score":177.81815},{"pmid":32196707,"title":"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.","text":["The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.","The outbreak of 2019 novel coronavirus (COVID-19) infection emerged in Wuhan, China, in December 2019. Since then the novel coronavirus pneumonia disease has been spreading quickly and many countries and territories have been affected, with major outbreaks in China, South Korea, Italy, and Iran. Influenza virus has been known as a common pathogen in winter and it can cause pneumonia. It was found clinically that very few patients were diagnosed with both COVID-19 and influenza virus. A total of 5 of the 115 patients confirmed with COVID-19 were also diagnosed with influenza virus infection, with three cases being influenza A and two cases being influenza B. In this study, we describe the clinical characteristics of those patients who got infected with COVID-19 as well as influenza virus. Common symptoms at onset of illness included fever (five [100%] patients), cough (five [100%] patients), shortness of breath (five [100%] patients), nasal tampon (three [60%] patients), pharyngalgia (three [60%] patients), myalgia (two [40%] patients), fatigue (two [40%] patients), headache (two [40%] patients), and expectoration (two [40%] patients). The laboratory results showed that compared to the normal values, the patients' lymphocytes were reduced (four [80%] patients), and liver functions alanine aminotransferase and aspartate aminotransferase (two [40%] patients and two [40%] patients) and C-reactive protein (four [80%] patients) were increased when admitted to hospital. They stayed in the hospital for 14, 30, 17, 12, and 19 days (28.4 +/- 7.02), respectively. The main complications for the patients were acute respiratory distress syndrome (one [20%] patients), acute liver injury (three [60%] patients), and diarrhea (two [40%] patients). All patients were given antiviral therapy (including oseltamivir), oxygen inhalation, and antibiotics. Three patients were treated with glucocorticoids including two treated with oral glucocorticoids. One of the five patients had transient hemostatic medication for hemoptysis. Fortunately, all patients did not need intensive care unit and were discharged from the hospital without death. In conclusion, those patients with both COVID-19 and influenza virus infection did not appear to show a more severe condition because based on the laboratory findings, imaging studies, and patient prognosis, they showed similar clinical characteristics as those patients with COVID-19 infection only. However, it is worth noting that the symptoms of nasal tampon and pharyngalgia may be more prone to appear for those coinfection patients.","J Med Virol","Ding, Qiang","Lu, Panpan","Fan, Yuhui","Xia, Yujia","Liu, Mei","32196707"],"abstract":["The outbreak of 2019 novel coronavirus (COVID-19) infection emerged in Wuhan, China, in December 2019. Since then the novel coronavirus pneumonia disease has been spreading quickly and many countries and territories have been affected, with major outbreaks in China, South Korea, Italy, and Iran. Influenza virus has been known as a common pathogen in winter and it can cause pneumonia. It was found clinically that very few patients were diagnosed with both COVID-19 and influenza virus. A total of 5 of the 115 patients confirmed with COVID-19 were also diagnosed with influenza virus infection, with three cases being influenza A and two cases being influenza B. In this study, we describe the clinical characteristics of those patients who got infected with COVID-19 as well as influenza virus. Common symptoms at onset of illness included fever (five [100%] patients), cough (five [100%] patients), shortness of breath (five [100%] patients), nasal tampon (three [60%] patients), pharyngalgia (three [60%] patients), myalgia (two [40%] patients), fatigue (two [40%] patients), headache (two [40%] patients), and expectoration (two [40%] patients). The laboratory results showed that compared to the normal values, the patients' lymphocytes were reduced (four [80%] patients), and liver functions alanine aminotransferase and aspartate aminotransferase (two [40%] patients and two [40%] patients) and C-reactive protein (four [80%] patients) were increased when admitted to hospital. They stayed in the hospital for 14, 30, 17, 12, and 19 days (28.4 +/- 7.02), respectively. The main complications for the patients were acute respiratory distress syndrome (one [20%] patients), acute liver injury (three [60%] patients), and diarrhea (two [40%] patients). All patients were given antiviral therapy (including oseltamivir), oxygen inhalation, and antibiotics. Three patients were treated with glucocorticoids including two treated with oral glucocorticoids. One of the five patients had transient hemostatic medication for hemoptysis. Fortunately, all patients did not need intensive care unit and were discharged from the hospital without death. In conclusion, those patients with both COVID-19 and influenza virus infection did not appear to show a more severe condition because based on the laboratory findings, imaging studies, and patient prognosis, they showed similar clinical characteristics as those patients with COVID-19 infection only. However, it is worth noting that the symptoms of nasal tampon and pharyngalgia may be more prone to appear for those coinfection patients."],"journal":"J Med Virol","authors":["Ding, Qiang","Lu, Panpan","Fan, Yuhui","Xia, Yujia","Liu, Mei"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196707","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.1002/jmv.25781","keywords":["covid-19","clinical characteristics","coinfection","influenza virus"],"locations":["Wuhan","China","China","South Korea","Italy","Iran","pharyngalgia","Wuhan","China"],"countries":["Italy","China","Korea, Republic of","Iran, Islamic Republic of"],"countries_codes":["ITA|Italy","CHN|China","KOR|Korea, Republic of","IRN|Iran, Islamic Republic of"],"e_drugs":["Oseltamivir"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490009550848,"score":171.57634},{"pmid":32371096,"title":"SARS-COV-2 was already spreading in France in late December 2019.","text":["SARS-COV-2 was already spreading in France in late December 2019.","The COVID-19 epidemic is believed to have started in late January 2020 in France. We report here a case of a patient hospitalized in December 2019 in our intensive care, of our hospital in the north of Paris, for hemoptysis with no etiological diagnosis and for which RT-PCR was performed retrospectively on the stored respiratory sample which confirmed the diagnosis of COVID-19 infection. Based on this result, it appears that the COVID-19 epidemic started much earlier.","Int J Antimicrob Agents","Deslandes, A","Berti, V","Tandjaoui-Lambotte, Y","Alloui, Chakib","Carbonnelle, E","Zahar, J R","Brichler, S","Cohen, Yves","32371096"],"abstract":["The COVID-19 epidemic is believed to have started in late January 2020 in France. We report here a case of a patient hospitalized in December 2019 in our intensive care, of our hospital in the north of Paris, for hemoptysis with no etiological diagnosis and for which RT-PCR was performed retrospectively on the stored respiratory sample which confirmed the diagnosis of COVID-19 infection. Based on this result, it appears that the COVID-19 epidemic started much earlier."],"journal":"Int J Antimicrob Agents","authors":["Deslandes, A","Berti, V","Tandjaoui-Lambotte, Y","Alloui, Chakib","Carbonnelle, E","Zahar, J R","Brichler, S","Cohen, Yves"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371096","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ijantimicag.2020.106006","keywords":["covid-19","intensive care unit"],"locations":["France","Paris","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Case Report"],"weight":1,"_version_":1666138496324075520,"score":160.11531}]}